论文部分内容阅读
目的探讨两种头孢菌素类药物在儿童支气管肺炎中的成本效果。方法所选100例支气管肺炎患儿均为本院2010年9月~2013年9月期间收治患儿,上述患儿随机分为观察组和对照组。观察组患儿给予头孢曲松治疗,对照组给予头孢他啶治疗。均连续治疗7 d。评定治疗效果。结果观察组总有效率与对照组总有效率近似,差异无统计学意义(P>0.05)。观察组成本效果为455/0.94=484.0;对照组成本效果为770/0.96=802.0。观察组成本效果低于对照组,观察组患儿治疗后,每取得一个治疗单位,其成本低于对照组。结论头孢曲松和头孢他啶治疗儿童支气管肺炎均获得较好临床治疗效果,但头孢曲松的治疗成本低于头孢他啶,值得借鉴。
Objective To investigate the cost-effectiveness of two cephalosporins in children with bronchopneumonia. Methods Selected 100 cases of children with bronchial pneumonia were treated in our hospital from September 2010 to September 2013, the children were randomly divided into observation group and control group. The observation group was treated with ceftriaxone and the control group with ceftazidime. Continuous treatment for 7 days. Assessment of treatment. Results The total effective rate in the observation group was similar to that in the control group, with no significant difference (P> 0.05). The effect of the observation group was 455 / 0.94 = 484.0; the effect of the control group was 770 / 0.96 = 802.0. The cost of the observation group was lower than that of the control group. After treatment, the cost of one treatment unit in the observation group was lower than that of the control group. Conclusion Ceftriaxone and ceftazidime are effective in treating bronchial pneumonia in children. However, the treatment cost of ceftriaxone is lower than that of ceftazidime, which is worth learning from.